GridPP4: The UK Grid for Particle Physics
Lead Research Organisation:
Queen Mary University of London
Department Name: Physics
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
Stephen Lloyd (Principal Investigator) | |
Alex Martin (Co-Investigator) |
Publications
Aad G
(2012)
Search for extra dimensions using diphoton events in 7 TeV proton-proton collisions with the ATLAS detector
in Physics Letters B
Aad G
(2013)
Search for new phenomena in events with three charged leptons at s = 7 TeV with the ATLAS detector
in Physical Review D
Aad G
(2014)
Measurements of normalized differential cross sections for t t ¯ production in p p collisions at ( s ) = 7 TeV using the ATLAS detector
in Physical Review D
Aad G
(2014)
Flavor tagged time-dependent angular analysis of the B s 0 ? J / ? ? decay and extraction of ? G s and the weak phase ? s in ATLAS
in Physical Review D
Aad G
(2012)
Observation of spin correlation in tt¯ events from pp collisions at vs=7 TeV using the ATLAS detector.
in Physical review letters
Aad G
(2012)
Measurement of W ± Z production in proton-proton collisions at $\sqrt{s}=7~\mbox{TeV}$ with the ATLAS detector
in The European Physical Journal C
Description | We have built a Grid to analyse data from the LHC at CERN and elsewhere. This enabled the discovery of the Higgs Boson, the fundamental scalar boson that is predicted to give mass to all other particles. |
Exploitation Route | Other disciplines can use our facilities or work with us to develop their own. |
Sectors | Digital/Communication/Information Technologies (including Software) |
URL | http://www.gridpp.ac.uk |
Description | Other disciplines have used our Grid for their own purposes. |
First Year Of Impact | 2008 |
Sector | Creative Economy,Digital/Communication/Information Technologies (including Software),Pharmaceuticals and Medical Biotechnology |
Impact Types | Societal |